Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares WHO classification of haematolymphoid tumours, fifth edition: myeloid and histiocytic neoplasms, CD47 and SIRP-alpha blockade, Hypomethylating agents (azacitidine, decitabine), Decitabine and the tag subtype-page.
Shares First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients, Hypomethylating agents (azacitidine, decitabine), Decitabine, Transfusion support and anaemia management and the tag subtype-page.
Shares WHO classification of haematolymphoid tumours, fifth edition: myeloid and histiocytic neoplasms, Conditioning regimen (myeloablative, reduced-intensity), Allogeneic stem cell transplant (allo-SCT), Allogeneic stem cell transplantation and the tag subtype-page.
Shares Hypomethylating agents (azacitidine, decitabine), Ivosidenib, Allogeneic stem cell transplantation, Azacitidine and the tag subtype-page.
Shares TP53-mutated (p53-abnormal), Allogeneic stem cell transplantation, Venetoclax, TP53 and the tag subtype-page.
Shares Revumenib, Allogeneic stem cell transplantation, Azacitidine, Venetoclax and the tag subtype-page.
Shares Conditioning regimen (myeloablative, reduced-intensity), Allogeneic stem cell transplant (allo-SCT), Transfusion support and anaemia management, Allogeneic stem cell transplantation and the tag subtype-page.
Shares TP53-mutated (p53-abnormal), Allogeneic stem cell transplantation, TP53 and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.